Pharmacokinetics

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability Trial in Baltimore (Low dose KT07, High dose KT07, Low dose

Completed
  • Healthy Adult Subjects
  • +2 more
  • Low dose KT07
  • +3 more
  • Baltimore, Maryland
    Pharmaron
Oct 13, 2022

Gram-Positive Bacterial Infections, Vancomycin, Pharmacokinetics Trial in Baltimore (Computer Decision Support Tool Intervention

Recruiting
  • Gram-Positive Bacterial Infections
  • +3 more
  • Computer Decision Support Tool Intervention Group
  • Matched Historical Controls
  • Baltimore, Maryland
    University of Maryland Medical Center
Apr 4, 2022

Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed
  • Acute Kidney Injury
  • +3 more
  • Baltimore, Maryland
    University of Maryland Medical Center
Sep 27, 2021

Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction, Chronic Heart Failure Trial in Worldwide (Omecamtiv

Completed
  • Modified Release Oral Formulation
  • +6 more
  • Omecamtiv Mecarbil Matrix F1 Formulation
  • +3 more
  • Mobile, Alabama
  • +100 more
Jul 25, 2021

Safety, Pharmacokinetics, Healthy Subjects Trial in Baltimore (Anifrolumab SC injection (300mg), Anifrolumab IV infusion

Completed
  • Safety
  • +2 more
  • Anifrolumab SC injection (300mg)
  • +5 more
  • Baltimore, Maryland
    Research Site
Feb 25, 2019

Cocaine Use, Pharmacokinetics Trial in Baltimore (cocaine, quinine, acetazolamide)

Completed
  • Cocaine Use
  • Pharmacokinetics
  • Baltimore, Maryland
    National Institute on Drug Abuse
Jul 3, 2018

Cannabis, Dependence, Cannabis Abuse Trial in Baltimore (Sativex(Registered Trademark), THC)

Completed
  • Cannabis
  • +4 more
  • Sativex(Registered Trademark)
  • THC
  • Baltimore, Maryland
    National Institute on Drug Abuse, Biomedical Research Center (BR
Jun 30, 2017

PET Imaging of Nicotinic Acetylcholine Receptors

Completed
  • Healthy Volunteers
  • +2 more
    • Baltimore, Maryland
      National Institute on Drug Abuse, Biomedical Research Center (BR
    Jun 30, 2017

    Relative Bioavailability, AUC, Cmax Trial in Baltimore (D1400147, D14000136, D14000137)

    Completed
    • Relative Bioavailability
    • +3 more
    • Baltimore, Maryland
      Research Site
    Mar 21, 2017

    Peanut Allergy, Immunotherapy, Pharmacokinetics Trial in Baltimore (sublingual film with peanut extract)

    Completed
    • Peanut Allergy
    • +2 more
    • sublingual film with peanut extract
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Feb 28, 2017